Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease
- PMID: 27760080
- DOI: 10.1097/MIB.0000000000000942
Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease
Comment in
-
Reply.Inflamm Bowel Dis. 2016 Nov;22(11):E44-E45. doi: 10.1097/MIB.0000000000000943. Inflamm Bowel Dis. 2016. PMID: 27755275 No abstract available.
Comment on
-
Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression.Inflamm Bowel Dis. 2016 Jun;22(6):1391-6. doi: 10.1097/MIB.0000000000000743. Inflamm Bowel Dis. 2016. PMID: 27057679 Clinical Trial.
Similar articles
-
Shingrix--an adjuvanted, recombinant herpes zoster vaccine.Med Lett Drugs Ther. 2017 Dec 4;59(1535):195-196. Med Lett Drugs Ther. 2017. PMID: 29186082 No abstract available.
-
Immunization: varicella-zoster vaccine.Cutis. 1979 Feb;23(2):144, 146-7, 152. Cutis. 1979. PMID: 217569 No abstract available.
-
Herpes zoster in a 2-year-old vaccinated against varicella.Dermatol Online J. 2014 Jan 15;20(1):21259. Dermatol Online J. 2014. PMID: 24456962
-
[Herpes zoster and postherpetic neuralgia: advantages of the vaccination].Rev Esp Quimioter. 2009 Nov;22 Suppl 1:19-21. Rev Esp Quimioter. 2009. PMID: 20084344 Review. Spanish. No abstract available.
-
[Immune responses to varicella-zoster virus infection].Nihon Rinsho. 2006 Mar;64 Suppl 3:184-7. Nihon Rinsho. 2006. PMID: 16615464 Review. Japanese. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical